Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
Clinical and Experimental Rheumatology
|
February 24, 2017
Integration of capillary microscopy and dermoscopy into the rheumatology fellow curriculum
Christopher Hatzis, Daniele Lerner, Stephen Paget, et al.
Seminars in Arthritis and Rheumatism
|
March 30, 2021
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial
Robert Spiera, Sebastian H Unizony, Min Bao, et al.
The Journal of Rheumatology
|
January 15, 2024
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series
Maryam Own, Aliza Bloostein, Robert Spiera, et al.
International Journal of Rheumatology
|
May 9, 2013
Design of the tocilizumab in giant cell arteritis trial
Sebastian H Unizony, Bhaskar Dasgupta, Elena Fisheleva, et al.
The Journal of Investigative Dermatology
|
August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.
Arthritis Research & Therapy
|
January 7, 2021
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Sebastian Unizony, Timothy J McCulley, Robert Spiera, et al.
The Journal of Rheumatology
|
April 15, 2025
Frailty and Associated Outcomes in Patients With Vasculitis
Sebastian E Sattui, John Stadler, Renee L Borchin, et al.
Clinical and Experimental Rheumatology
|
October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial
Julio C Mantero, Nina Kishore, Jessica Ziemek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 8, 2014
Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's)
Gunnar Tomasson, John C Davis, Gary S Hoffman, et al.
The Journal of Rheumatology
|
June 17, 2016
The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil
Ami A Shah, Elena Schiopu, Soumya Chatterjee, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
Clinical and Experimental Rheumatology
|
February 24, 2017
Integration of capillary microscopy and dermoscopy into the rheumatology fellow curriculum
Christopher Hatzis, Daniele Lerner, Stephen Paget, et al.
Seminars in Arthritis and Rheumatism
|
March 30, 2021
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial
Robert Spiera, Sebastian H Unizony, Min Bao, et al.
The Journal of Rheumatology
|
January 15, 2024
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series
Maryam Own, Aliza Bloostein, Robert Spiera, et al.
International Journal of Rheumatology
|
May 9, 2013
Design of the tocilizumab in giant cell arteritis trial
Sebastian H Unizony, Bhaskar Dasgupta, Elena Fisheleva, et al.
The Journal of Investigative Dermatology
|
August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.
Arthritis Research & Therapy
|
January 7, 2021
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Sebastian Unizony, Timothy J McCulley, Robert Spiera, et al.
The Journal of Rheumatology
|
April 15, 2025
Frailty and Associated Outcomes in Patients With Vasculitis
Sebastian E Sattui, John Stadler, Renee L Borchin, et al.
Clinical and Experimental Rheumatology
|
October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial
Julio C Mantero, Nina Kishore, Jessica Ziemek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 8, 2014
Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's)
Gunnar Tomasson, John C Davis, Gary S Hoffman, et al.
The Journal of Rheumatology
|
June 17, 2016
The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil
Ami A Shah, Elena Schiopu, Soumya Chatterjee, et al.
Page
of 10